Pancreatic cancer treatment costs, including patient liability, by phase of care and treatment modality, 2000-2013.

ABSTRACT:

Objectives

Our study provides phase-specific cost estimates for pancreatic cancer based on stage and treatment. We compare treatment costs between the different phases and within the stage and treatment modality subgroups.

Methods

Our cohort included 20,917 pancreatic cancer patients from the Surveillance, Epidemiology, and End Results (SEER)-Medicare database diagnosed between 2000 and 2011. We allocated costs into four phases of care-staging (or surgery), initial, continuing, and terminal- and calculated the total, cancer-attributable, and patient-liability costs in 2018 US dollars. We fit linear regression models using log transformation to determine whether costs were predicted by age and calendar year.

Results

Monthly cost estimates were high during the staging a

SUBMITTER: Tramontano AC 

PROVIDER: S-EPMC6919520 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature